Literature DB >> 3349666

The growth and metastasis of four commonly used tumour lines implanted into eight different sites: evidence for site and tumour effects.

W S Chan1, C M Page, J R Maclellan, G A Turner.   

Abstract

The growth and metastasis of four commonly used experimental tumour lines have been compared after the implantation of cells into a lobe of the liver, the spleen, the left kidney, the peritoneal cavity, the thorax, the right thigh muscle, subcutaneously into the dorsolumbar region and intravenously into the tail vein or the right femoral vein. This was done to assess the importance of site in affecting metastatic distribution, and to determine whether any general conclusions could be drawn as to the role of this factor. Tumours grew at variable rates in different sites, but this did not affect the extent or distribution of metastasis. Each line gave a characteristic pattern that could be considerably modified by site. For example, in the spleen, metastasis was always extensively to the liver; in the kidney, and to some extent in the muscle, metastasis was similar to that obtained for intravenously injected cells; in the peritoneal cavity or thorax, metastasis was usually lower than from other sites; and in the liver, the metastasis to other lobes of the liver and to the lungs was modified. Many of these findings could be explained by both specific and non-specific factors operating at each site. It is suggested that interactions at the primary site of tumour growth may be very important in affecting metastasis, and that in the future more attention should be given to this factor in order to make progress in understanding tumour spread.

Entities:  

Mesh:

Year:  1988        PMID: 3349666     DOI: 10.1007/bf01782483

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  12 in total

1.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

2.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

3.  Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice.

Authors:  I Malavé; I Blanca; H Fuji
Journal:  J Natl Cancer Inst       Date:  1979-01       Impact factor: 13.506

4.  Organ vascularity and metastatic frequency.

Authors:  L Weiss; K Haydock; J W Pickren; W W Lane
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

Review 5.  Influence of implantation site on formation of metastases.

Authors:  C Meyvisch
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice.

Authors:  R Giavazzi; D E Campbell; J M Jessup; K Cleary; I J Fidler
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

7.  Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth.

Authors:  I R Hart; J E Talmadge; I J Fidler
Journal:  Cancer Res       Date:  1981-04       Impact factor: 12.701

8.  Metastatic patterns and target organ arterial blood flow.

Authors:  L Weiss; J Bronk; J W Pickren; W W Lane
Journal:  Invasion Metastasis       Date:  1981

9.  Differences in surface expression of WGA-binding proteins of cells from a lymphosarcoma and its liver metastases.

Authors:  W S Chan; A Jackson; G A Turner
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

10.  Radioiodination studies of tumour cell-surface proteins after different disaggregation procedures.

Authors:  D Guy; A L Latner; G A Turner
Journal:  Br J Cancer       Date:  1977-08       Impact factor: 7.640

View more
  6 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

2.  Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases.

Authors:  Martin Grimm; Martin Gasser; Marco Bueter; Johanna Strehl; Johann Wang; Ekaterina Nichiporuk; Detlef Meyer; Christoph T Germer; Ana M Waaga-Gasser; Andreas Thalheimer
Journal:  BMC Cancer       Date:  2010-03-07       Impact factor: 4.430

3.  New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination.

Authors:  Lan G Coffman; Daniela Burgos-Ojeda; Rong Wu; Kathleen Cho; Shoumei Bai; Ronald J Buckanovich
Journal:  Transl Res       Date:  2016-03-30       Impact factor: 7.012

4.  Experimental liver metastasis: standards for local cell implantation to study isolated tumor growth in mice.

Authors:  Otto Kollmar; Martin K Schilling; Michael D Menger
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  Alcohol consumption suppresses metastasis of B16-BL6 melanoma in mice.

Authors:  G G Meadows; C A Elstad; S E Blank; R M Gallucci; L J Pfister
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

6.  Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment.

Authors:  Sebastian A Wohlfeil; Verena Häfele; Bianca Dietsch; Céline Weller; Carsten Sticht; Anna Sophia Jauch; Manuel Winkler; Christian David Schmid; Anna Lena Irkens; Ana Olsavszky; Kai Schledzewski; Philipp-Sebastian Reiners-Koch; Sergij Goerdt; Cyrill Géraud
Journal:  J Transl Med       Date:  2022-02-02       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.